Systematic Reviews of Treatments for Tuberculosis

Follow the links below to find systematic reviews of the evidence of the effectiveness of treatments for tuberculosis.

Reviewed December 2011

17 Resources Found

Results 1 to 17 displayed.

Title:   Nutritional supplements for people being treated for active tuberculosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Researchers in The Cochrane Collaboration conducted a review of the effects of nutritional supplements for people being treated for tuberculosis. After searching for relevant studies, they identified 23 relevant articles. Their findings are summarized b...
Date:   Jul 2011
Title:   Screening programmes for tuberculosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Tuberculosis is a serious infectious disease that affects over nine million people each year. The disease is spread by airborne droplets, which arise in the infected lungs of tuberculosis patients. Despite widespread availability of treatment with effec...
Date:   Apr 2011
Title:   The effect of lay health workers on mother and child health and infectious diseases
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   A review of the effect of using lay health workers to improve mother and child health and to help people with infectious diseases was carried out by researchers in The Cochrane Collaboration. After searching for all relevant studies, they found 82 studi...
Date:   Oct 2009
Title:   Not enough evidence to support using low level laser therapy alongside drug treatments for tuberculosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Tuberculosis (TB) is a serious bacterial infection that can affect different parts of the body; most frequently it affects the lungs (pulmonary TB). Some bacteria can be drug resistant, and some people may have the infection alongside another medical co...
Date:   Oct 2009
Title:   Treatment of latent tuberculosis (TB) with isoniazid in people infected with HIV reduces their risk of developing active TB
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Most people infected with tuberculosis (TB) never get TB symptoms. This is called latent TB. People infected with HIV/AIDS are at increased risk of getting TB and about 30% of people with HIV who have latent TB will eventually get active TB. This result...
Date:   Oct 2008
Title:   Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This review aimed to assess the effects of reminder systems and late patient tracers on patients' adherence to medical advice (such as attending clinic appointments for taking anti-tuberculosis drugs) and on clinical outcomes (such as cure of tubercul...
Date:   Jun 2008
Title:   Corticosteroids for managing tuberculous meningitis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Tuberculous meningitis is a serious form of tuberculosis affecting the meninges covering the brain and spinal cord. The clinical outcome is poor even when treated with conventional antituberculous drugs. Corticosteroids are commonly used in addition to ...
Date:   Nov 2007
Title:   Not enough evidence on the routine use of surgery in addition to drug treatment for people with tuberculosis of the spine
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Spinal tuberculosis (spinal TB) occurs in about 1% to 2% of people with TB (the most common infectious disease in the world). The disease can have a major impact on people's lives. Nerves can be squeezed causing pain, loss of feeling, and breathing prob...
Date:   Oct 2007
Title:   Directly observing people taking their tuberculosis drugs did not improve the cure rate compared with people without direct monitoring of treatment
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Using a pilot system we have categorised this review as: Current question - no update intended (Results conclusive). Please see
Date:   Aug 2007
Title:   No clear evidence that corticosteroids are effective for tuberculous
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Tuberculous pleural effusion results from tuberculous infection of the membrane covering of the lungs. This results in a build up of fluid around the lung that impairs breathing and may lead to restriction of lung function in the long term. Some clinici...
Date:   Jul 2007
Title:   Rifabutin for treating pulmonary tuberculosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Among current challenges in tuberculosis treatment are reducing the length of time that drugs must be taken to less than six months and finding ways to safely combine tuberculosis drugs with those used in the treatment of HIV infection. Rifabutin is a d...
Date:   Jul 2007
Title:   The impact of tuberculosis preventive therapy on tuberculosis and death in HIV-infected children
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Tuberculosis (TB) is a common cause of severe lung disease and death in children infected with HIV, particularly those living in areas of high tuberculosis prevalence. Hence preventing TB infection and disease in HIV-infected children is desirable and p...
Date:   Mar 2006
Title:   There is insufficient evidence to compare equivalence of effect between fully intermittent and daily treatment in adult patients with pulmonary tuberculosis.
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Rifampicin-containing drug combinations can achieve high cure rates in patients with pulmonary tuberculosis when given for six months. Such treatment can be given either daily or intermittently (eg three times a week) from the beginning. This review com...
Date:   Sep 2005
Title:   Isoniazid is effective in helping to prevent tuberculosis in people not infected with HIV
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Tuberculosis (TB) is a serious bacterial infection and it is estimated that about a third of the world's population is infected with TB. There are a number of types, such as pulmonary TB (bacteria residing in a person's lungs) and spinal TB (in the spin...
Date:   May 2003
Title:   No benefit from immunotherapy with Mycobacterium vaccae in people with tuberculosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Injections that aim to influence a person's immune system have been used by doctors to lessen the chance of a person developing a disease, or sometimes to reduce the damage the disease does to the body. M. vaccae is a type of bacterium related to the on...
Date:   Oct 2002
Title:   Tuberculosis infection of the membrane around the heart is uncommon but life threatening. There is little reliable research on best practice in relation to what drugs to give and when and how to operate.
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Currently doctors prescribe antituberculous drugs and remove the membrane if it is making the patient ill. However, doctors vary in the way they manage this condition in terms of what antituberculous drugs to give and when to operate. We found no clinic...
Date:   Jun 2002
Title:   Regimens of less than six months for treating tuberculosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Plain language summary pending
Date:   Jun 1999

Results 1 to 17 displayed.